May 27, 2020
Amivas (US), LLC Announces FDA Approval of Artesunate for Injection for Treatment of Severe Malaria
May 26, 2020
FDA Approves Only Drug in U.S. to Treat Severe Malaria
May 13, 2020
Hydroxychloroquine Market Size Worth Around US$ 6 Bn by 2027
May 11, 2020
Malaria Diagnostics Market to Reach $1,085,106 Thousand, Globally, by 2026 at 5.1% CAGR: Allied Market Research
May 04, 2020
Global Anti-Malarial Drugs Market (by Drug Type, Anti-Malarial Activity, End-Users & Region): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
Apr 24, 2020
Coronavirus (COVID-19) Update: FDA Reiterates Importance of Close Patient Supervision for 'Off-Label' Use of Antimalarial Drugs to Mitigate Known Risks, Including Heart Rhythm Problems
Apr 22, 2020
Ocean Biomedical Announces Groundbreaking Malaria Vaccine Discovery
Apr 16, 2020
Science and Technology Daily: Chinese Approach on Medical Treatment against COVID-19
Apr 09, 2020
Cigna Helps Accelerate Research For A COVID-19 Treatment By Donating Medications To Washington University School Of Medicine's Clinical Trial
Apr 08, 2020
65 Percent of Physicians in New Survey Would Give Anti-Malaria Drugs to Their Own Family to Treat COVID-19
Mar 26, 2020
The Cardiac Risk of Chloroquine in Unapproved Indications
Mar 26, 2020
Innoplexus Announces Major Findings in Potential Combination Therapies for COVID-19
Mar 26, 2020
March 26 Statement: Lupus Research Alliance Puts Plaquenil Shortage Into Perspective For Lupus Community
Feb 28, 2020
The Quinism Foundation Calls on GSK to Take Action to Better Emphasize Limitations of Use for Krintafel® (Tafenoquine)
Feb 28, 2020
The Quinism Foundation Calls on GSK to Take Action to Better Emphasize Limitations of Use for Krintafel® (Tafenoquine)
Feb 28, 2020
The Quinism Foundation Calls on GSK to Take Action to Better Emphasize Limitations of Use for Krintafel® (Tafenoquine)
Aug 08, 2019
The Quinism Foundation Calls On the U.K. Science Media Centre to Issue an Immediate Correction to a Potentially Endangering Release on the Risk Profile of Mefloquine
Apr 26, 2019
ExxonMobil Continues Support for Fight Against Malaria
Apr 23, 2019
PATH and MMV launch 5-year global initiative to support elimination of relapsing malaria
Mar 27, 2019
GHIT Fund Announces New Investments: A Total of 2.86 Billion Yen in Drug for Schistosomiasis, Dengue, Malaria and Tuberculosis, Vaccines for Leishmaniasis and Malaria, and Diagnostics for Tuberculosis